XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings per Share | 6 Months Ended
--- | ---
Jun. 30, 2021
Earnings Per Share [Abstract] |
Earnings per Share | Earnings per Share The following table sets forth the calculation of basic and diluted earnings per share for the three and six months ended June 30, 2021 and 2020 (in thousands, except share and per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Basic net income per share: |  |  |  |  |  |  |
Net income | $ | 24,359 |  |  | $ | 11,464 |  |  | $ | 60,865 |  |  | $ | 39,566 |
Weighted-average common shares outstanding during the period | 33,622,666 |  |  | 31,435,941 |  |  | 33,367,734 |  |  | 32,007,114 |
Basic net income per share | $ | 0.72 |  |  | $ | 0.36 |  |  | $ | 1.82 |  |  | $ | 1.24 |
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Diluted net income per share: |  |  |  |  |  |  |
Net income | $ | 24,359 |  |  | $ | 11,464 |  |  | $ | 60,865 |  |  | $ | 39,566 |
Basic shares outstanding during the period | 33,622,666 |  |  | 31,435,941 |  |  | 33,367,734 |  |  | 32,007,114 |
Plus: Common stock equivalents associated with stock option awards | 3,064,364 |  |  | 2,367,524 |  |  | 1,984,711 |  |  | 2,407,882 |
Diluted shares outstanding | 36,687,030 |  |  | 33,803,465 |  |  | 35,352,445 |  |  | 34,414,996 |
Diluted net income per share | $ | 0.66 |  |  | $ | 0.34 |  |  | $ | 1.72 |  |  | $ | 1.15 |
The computation of diluted shares outstanding for the three months ended June 30, 2021 did not exclude any shares whose effect would have been anti-dilutive, while the computation of diluted shares outstanding for the six months ended June 30, 2021 excluded 0.4 million outstanding stock options, less than 0.1 million of ESPP shares, and 10.5 million of outstanding stock warrants, as their effect would have been anti-dilutive. The computation of diluted shares outstanding for the both the three and six months ended June 30, 2020 excluded 4.6 million outstanding stock options and 10.5 million of stock warrants, as their effect would have been anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration